2014
DOI: 10.1016/j.ejmg.2014.09.004
|View full text |Cite
|
Sign up to set email alerts
|

Clinico-pathological manifestations of variant late infantile neuronal ceroid lipofuscinosis (vLINCL) caused by a novel mutation in MFSD8 gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 15 publications
0
16
0
Order By: Relevance
“…Even though the strength of this association is slightly above our threshold for statistical significance after multiple testing correction (P Bo nf < 0.05), we pursued this finding in follow-up studies for several reasons. First, prior studies have found that recessive pathogenic variants in MFSD8 cause late infantile neuronal ceroid lipofuscinosis (NCL) [2, 30, 40, 67], a childhood neurodegenerative lysosomal-storage disorder. Second, the link between MFSD8 and NCL is akin to observations with GRN, for which heterozygous pathogenic variants result in autosomal dominant FTLD and homozygous pathogenic variants cause NCL.…”
Section: Resultsmentioning
confidence: 99%
“…Even though the strength of this association is slightly above our threshold for statistical significance after multiple testing correction (P Bo nf < 0.05), we pursued this finding in follow-up studies for several reasons. First, prior studies have found that recessive pathogenic variants in MFSD8 cause late infantile neuronal ceroid lipofuscinosis (NCL) [2, 30, 40, 67], a childhood neurodegenerative lysosomal-storage disorder. Second, the link between MFSD8 and NCL is akin to observations with GRN, for which heterozygous pathogenic variants result in autosomal dominant FTLD and homozygous pathogenic variants cause NCL.…”
Section: Resultsmentioning
confidence: 99%
“…Retinal degeneration leading to visual impairment and ultimately blindness during the course of the disease has been reported as a typical neurologic symptom in patients with CLN7 with vLINCL phenotype, 7,8,[15][16][17][18][19]21,22,45 in a naturally occurring CLN7 canine model, 46 and in a hypomorphic mouse model of CLN7 disease. 11 However, precise information about the onset and progression of the retinal pathology, the affected retinal layers and retinal cell types, and the biochemical alterations associated with CLN7 disease, vLINCL phenotype, are largely missing.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, approximately 90% of patients with CLN7 develop visual failure during the course of the disease. 7,16,18,19,21,45,51 The morphologic and biochemical alterations in the retina of patients with CLN7 are, however, largely unknown and limited to morphologic data obtained from postmortem tissues of patients with vLINCL phenotype at the end stage of the disease. 15,22 Morphologic analyses of retinas from two patients with CLN7 aged 7 and 9 years and carrying the missense mutation p.Thr294Lys revealed a progressive retinal degeneration, with a complete loss of photoreceptor cells and a marked reduction of neuron numbers in the inner nuclear layer and the ganglion cell layer.…”
Section: Discussionmentioning
confidence: 99%
“…The consequences of MFSD8 mutation may be synaptic dysfunction resulting in disordered neurotransmitter release and local excitotoxicity. This may lead to downstream secondary consequences that have been described such as the accumulation of aggregate storage material in neuronal cells, 5,16,31,32 impaired autophagy, 33 and cell death, as well as accompanying inflammation that occurs both in the brains of MFSD8-deficient patients 31 and in the MFSD8-knockout dog 34 and mouse models. 33,35 All previously published MFSD8 mutation combinations associated with disease are listed at http://www.ucl.ac.uk/ncl/ and Alexa Fluor 568-conjugated secondary antibody (red) or Alexa Fluor 488-conjugated secondary antibody (green) and DAPI nuclear counterstain (blue) are shown.…”
Section: Figurementioning
confidence: 99%